Clinical Trials Browser

Phase 2 × Cognitive Dysfunction × Cannabidiol × Clear all

NCT04447846 2023-05-25

Novel Cognitive Treatment Targets for Epidiolex in Sturge- Weber Syndrome

Phase 2 Completed

11 enrolled 25 charts

Sturge-Weber Syndrome, Cognitive Dysfunction